Half Year Results 

Alliance Pharma prepares for more acquisitions

Alliance Pharma prepares for more acquisitions

In the six months to June 2019, Alliance Pharma (APH) produced enough cash to increase the half-year dividend by 10 per cent and reduce net debt by more than £11m. As promised, leverage has fallen to less than two times adjusted cash profits, from 2.3 times at the end of 2018, thanks to the robust local brands portfolio that generates “significant profit and cash flow for the business”.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now